フローサイトメトリーの市場規模、シェア、動向分析レポート：製品別、技術別、最終用途別、地域別、セグメント別予測、2024年～2030年

フローサイトメトリー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のフローサイトメトリー市場規模は2030年までに70億1,000万米ドルに達し、予測期間中のCAGRは6.96％を記録すると予測されています。

この技術の技術的進歩は、ポイントオブケア（PoC）検査用のマイクロ流体フローサイトメトリーの開発など、新しく改良された分析ツールを導入しています。さらに、がん、免疫不全症、感染症の有病率の上昇が業界を牽引しています。さらに、バイオ医薬品、ライフサイエンス、バイオテクノロジーの研究活動における研究開発投資の増加が、フローサイトメトリー装置の高い需要につながっています。最近の動向では、PoC検査用のポータブルなマイクロ流体フローサイトメトリー装置の開発に重点が置かれています。

マイクロフルイディクスとフローサイトメトリーを併用することで、生物学的サンプルの複数の特性を測定する有用なツールとなります。例えば、いくつかのマイクロ流体や小型化された検出器が容易に入手できるようになったことで、オプトフルイディックサイトメーター、イメージングサイトメーター、インピーダンスサイトメーターといったマイクロチップを用いたサイトメーターの開発が可能になった。コスト効率が高く、携帯可能でコンパクトなマイクロ流体フローサイトメトリー装置の開発は有益です。これらはアジアやアフリカなどの新興経済諸国では手頃な価格で入手可能であり、PoC検査用途の急速な成長を可能にしています。さらに、蛍光色素の改良と学術研究環境におけるベンチトップサイトメーターの有用性の増加が、業界を牽引すると予想されます。

マルチカラーフローサイトメトリーの開発は、新薬開発活動におけるこの技術の採用を加速しています。例えば、2020年1月、ベックマン・コールター・ライフサイエンシズから13色の臨床用フローサイトメトリーシステムであるDxFLEX、CE-IVDが欧州で発売されました。同様に、複数のパラメーターの同時評価による簡便な細胞解析により、このような装置は受託研究目的で広く使用されています。COVID-19の大流行も、この分野の新製品の発売によって証明されているように、技術の革新に拍車をかけた。例えば、2021年7月、Metropolis Healthcare Ltd.は、COVID-19入院患者のリスク状態を検出する簡単な血液検査であるCoviRisk-TBNKを発売しました。

この検査は、ICUへの入室や人工呼吸の必要性を分析し、医療資源への負担を軽減するのに役立ちます。この検査はフローサイトメトリーベースのリンパ球サブセットアッセイで、体外診断用医薬品の承認を受けています。このような技術革新は近い将来、業界の成長を促進すると予想されます。さらに、フローサイトメトリーは免疫細胞をリストアップし、その特徴を明らかにする重要なツールであり、根本的な遺伝的欠陥の認識と検証にも役立ちます。この技術は、幹細胞移植後の患者の免疫反応を観察・モニターするためにも使用されるため、臓器移植は業界の成長を後押しする重要な役割を担っています。WHOによると、世界では毎年約5万件の幹細胞移植が行われており、この数は将来の展望を広げ、この技術の応用範囲を広げると予想されています。

その反面、装置は非常に高価であるため、発展途上国では技術的に高度なフローサイトメトリー装置を購入する余裕がない場合があります。これらの装置は10万米ドル以上することもあり、中小規模の病院や臨床検査室にとっては予算的に大きな制約となります。しかし、ソニーのような一部のメーカーは、多くのプロセスを自動化するソフトウェアを使用した、より新しい装置を発売しようとしています。このような開発は、技術の使い勝手を向上させるだけでなく、近い将来、平均装置コスト（10万米ドル以下）を引き下げるのに役立つと思われます。

フローサイトメトリー市場レポートハイライト

• 装置製品セグメントは、技術の進歩、慢性疾患の有病率の増加により、2023年に最大シェアを占めました。
• 細胞ベースのフローサイトメトリー技術は、早期診断に対する高い需要と細胞ベースのアッセイの関連する利点に関する意識の高まりにより、2023年に業界を支配しました。
• 用途別では、インフルエンザ、HIV、COVID-19などの感染症に関する活動の増加により、臨床セグメントが2023年に最大の収益シェアを占めました。
• 学術機関のエンドユーザーセグメントは、学術機関や研究センターによる研究開発活動の増加により、2023年の市場をリードしました。
• 北米は、科学的に先進的なフローサイトメトリーソリューションの導入が進んでいること、ヘルスケア支出が多いこと、医療インフラが整備されていることから、2023年に市場をリードしました。
• アジア太平洋は、2022年から2030年にかけて最も速いCAGRを記録すると予測されています。これは、中国やインドなどの新興国における製薬およびバイオテクノロジー産業の広範な成長によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
  • 業界の課題
• ビジネス環境分析
  • PESTEL分析
  • ポーターのファイブフォース分析
• COVID-19の影響分析

第4章 フローサイトメトリー市場- セグメント分析、製品別、2018年～2030年

• フローサイトメトリー市場：製品変動分析
• 製品別
  • 機器
  • 試薬・消耗品
  • ソフトウェア
  • アクセサリー
  • サービス

第5章 フローサイトメトリー市場- 技術別セグメント分析、2018年～2030年

• フローサイトメトリー市場：技術変動分析
• テクノロジー別

第6章 フローサイトメトリー市場- セグメント分析、用途別、2018年～2030年

• フローサイトメトリー市場：用途変動分析
• 用途別
  • 研究
  • 産業
  • 臨床

第7章 フローサイトメトリー市場- セグメント分析、最終用途別、2018年～2030年

• フローサイトメトリー市場：最終用途変動分析
• 最終用途別

第8章 フローサイトメトリー市場：地域推定・動向分析、製品、技術、用途、最終用途別

• フローサイトメトリー市場：地域別展望
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業プロファイル
  • DANAHER CORPORATION
  • BECTON, DICKINSON AND COMPANY（BD）
  • SYSMEX CORPORATION
  • AGILENT TECHNOLOGIES, INC.
  • APOGEE FLOW SYSTEMS LTD.
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • STRATEDIGM, INC.
• 企業分類
• フローサイトメトリー市場シェア分析、2023年
• 戦略マッピング
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新製品発売
  • その他

第10章 結論

List of Tables

• Table 1 List of secondary sources
• Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
• Table 3 CPT codes for flow cytometry reimbursement
• Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
• Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 22 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 23 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 24 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 25 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 26 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 27 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 28 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 29 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 30 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 31 U.K. flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 32 U.K. flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 33 U.K. flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 34 U.K. flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 35 France flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 36 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 37 France flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 38 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 39 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 40 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 41 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 42 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 43 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 44 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 45 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 46 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 47 Denmark flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 48 Denmark flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 49 Denmark flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 50 Denmark flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 51 Sweden flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 52 Sweden flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 53 Sweden flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 54 Sweden flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 55 Norway flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 56 Norway flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 57 Norway flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 58 Norway flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 59 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 60 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 61 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 62 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 63 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 64 China flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 65 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 66 China flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 67 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 68 India flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 69 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 70 India flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 71 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 72 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 73 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 74 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 75 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 76 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 77 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 78 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 79 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 80 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 81 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 82 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 83 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 84 Thailand flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 85 Thailand flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 86 Thailand flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 87 Thailand flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 88 Singapore flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 89 Singapore flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 90 Singapore flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 91 Singapore flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 92 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 93 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 94 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 95 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 96 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 97 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 98 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 99 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 100 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 101 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 102 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 103 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 104 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 105 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 106 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 107 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 108 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 109 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 110 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 111 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 112 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 113 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 114 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 115 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 116 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 117 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 118 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 119 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 120 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 121 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 122 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 123 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 124 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 125 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 126 Kuwait flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 127 Kuwait flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 128 Kuwait flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 129 Kuwait flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 130 Company Market Share Analysis, 2023

List of Figures

• Fig. 1 Flow cytometry market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Value chain based sizing & forecasting
• Fig. 6 QFD modelling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Product and technology segment snapshot
• Fig. 10 Application and end-use segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Life science tools market value, 2023 (USD Billion)
• Fig. 13 Market dynamics
• Fig. 14 PESTEL analysis
• Fig. 15 Porter's five forces analysis
• Fig. 16 Flow cytometry market: Product outlook and key takeaways
• Fig. 17 Flow cytometry market: Product movement analysis
• Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Cell analyzers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Cell sorters market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Reagents & consumables market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 22 Software market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 23 Accessories market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 25 Flow cytometry market: Technology outlook and key takeaways
• Fig. 26 Flow cytometry market: Technology movement analysis
• Fig. 27 Cell-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Bead-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Flow cytometry market: Application outlook and key takeaways
• Fig. 30 Flow cytometry market: Application movement analysis
• Fig. 31 Research market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Pharmaceutical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Stem cell market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 In vitro toxicity market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Apoptosis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Cell sorting market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Cell cycle analysis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Cell viability market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Industrial market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Organ transplantation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Immunodeficiency market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Autoimmune disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Flow cytometry market: End-use outlook and key takeaways
• Fig. 49 Flow cytometry market: End-use movement analysis
• Fig. 50 Commercial organizations market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 CROs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Academic institutes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Clinical testing labs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Flow cytometry market revenue, by region, 2023 & 2030 (USD Million)
• Fig. 58 Regional marketplace: Key takeaways
• Fig. 59 Regional marketplace: Key takeaways
• Fig. 60 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 U.S. flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Canada flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Europe flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 UK flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Germany flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 France flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Italy flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Spain flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 Denmark flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Sweden flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Norway flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Asia Pacific flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Japan flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 China flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 India flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Australia flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Thailand flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 South Korea flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Singapore flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 Rest of Asia Pacific flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Latin America flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Key country dynamics
• Fig. 101 Brazil flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 Mexico flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Key country dynamics
• Fig. 105 Argentina flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Rest of Latin America flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 107 MEA flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Key country dynamics
• Fig. 109 South Africa flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 110 Key country dynamics
• Fig. 111 Saudi Arabia flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 112 Key country dynamics
• Fig. 113 UAE flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 114 Key country dynamics
• Fig. 115 Kuwait flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 116 Rest of MEA flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 117 Key company categorization
• Fig. 118 Flow cytometry market share analysis, 2023
• Fig. 119 Strategy mapping

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 6.96% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

• The instrument product segment held the largest share in 2023 due to technical advancements, as well as increased prevalence of chronic conditions
• The cell-based flow cytometry technology dominated the industry in 2023 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
• By application, the clinical segment accounted for the largest revenue share in 2023 owing to increased activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
• The academic institutes end-user segment led the market in 2023 owing to increased R&D activities by academic institutes & research centers
• North America was the leading region in 2023 due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
• Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Regional Scope
  • 1.1.2 Market Definitions
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Objectives
  • 1.2.1 Objective - 1
  • 1.2.2 Objective - 2
  • 1.2.3 Objective - 3
• 1.3 Research Methodology
• 1.4 Information Procurement
  • 1.4.1 Purchased Database
  • 1.4.2 GVR's Internal Database
  • 1.4.3 Secondary Sources
  • 1.4.4 Primary Research
  • 1.4.5 Details Of Primary Research
• 1.5 Information or Data Analysis
  • 1.5.1 Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
  • 1.7.1 Commodity Flow Analysis
    • 1.7.1.1 Approach 1: Commodity Flow Approach
    • 1.7.1.2 Approach 2: Country wise market estimation using bottom-up approach
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Product and Technology Segment Snapshot
• 2.3 Application and End-use Segment Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, and Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Growing prevalence of chronic and infectious diseases
    • 3.2.1.2 High R&D investments in biotechnology, clinical, and life science research
    • 3.2.1.3 Technological advancements in flow cytometry instruments and reagents
    • 3.2.1.4 Increasing demand for point-of-care diagnostics
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 High Cost Of Instruments
  • 3.2.3 Industry Challenges
    • 3.2.3.1 Low Cell Throughput Rate
• 3.3 Business Environment Analysis
  • 3.3.1 Pestel Analysis
  • 3.3.2 Porter's Five Forces Analysis
• 3.4 COVID-19 Impact Analysis

Chapter 4 Flow Cytometry Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 4.1 Flow Cytometry Market: Product Movement Analysis
• 4.2 Flow Cytometry Market Estimates & Forecast by Product (USD Million)
  • 4.2.1 Instruments
    • 4.2.1.1 Cell Analyzers
    • 4.2.1.2 Cell Sorters
  • 4.2.2 Reagents & Consumables
  • 4.2.3 Software
  • 4.2.4 Accessories
  • 4.2.5 Services

Chapter 5 Flow Cytometry Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)

• 5.1 Flow Cytometry Market: Technology Movement Analysis
• 5.2 Flow Cytometry Market Estimates & Forecast by Technology (USD Million)
  • 5.2.1 Cell-Based
  • 5.2.2 Bead-Based

Chapter 6 Flow Cytometry Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

• 6.1 Flow Cytometry Market: Application Movement Analysis
• 6.2 Flow Cytometry Market Estimates & Forecast by Application (USD Million)
  • 6.2.1 Research
    • 6.2.1.1 Pharmaceutical
    • 6.2.1.1.1 Drug Discovery
    • 6.2.1.1.2 Stem Cell
    • 6.2.1.1.3 In Vitro Toxicity
    • 6.2.1.2 Apoptosis
    • 6.2.1.3 Cell Sorting
    • 6.2.1.4 Cell Cycle Analysis
    • 6.2.1.5 Immunology
    • 6.2.1.6 Cell Viability
  • 6.2.2 Industrial
  • 6.2.3 Clinical
    • 6.2.3.1 Cancer
    • 6.2.3.2 Organ Transplantation
    • 6.2.3.3 Immunodeficiency
    • 6.2.3.4 Hematology
    • 6.2.3.5 Autoimmune Disorders

Chapter 7 Flow Cytometry Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

• 7.1 Flow Cytometry Market: End-use Movement Analysis
• 7.2 Flow Cytometry Market Estimates & Forecast by End Use (USD Million)
  • 7.2.1 Commercial Organizations
    • 7.2.1.1 Biotechnology Companies
    • 7.2.1.2 Pharmaceutical Companies
    • 7.2.1.3 Cros
  • 7.2.2 Hospitals
  • 7.2.3 Academic Institutes
  • 7.2.4 Clinical Testing Labs

Chapter 8 Flow Cytometry Market: Regional Estimates and Trend Analysis, By Product, Technology, Application, and End Use

• 8.1 Flow Cytometry Market: Regional Outlook
• 8.2 North America
  • 8.2.1 North America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 Key Country Dynamics
    • 8.2.2.2 U.S. Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2.3 Competitive/Market Scenario
    • 8.2.2.4 Regulatory Framework
    • 8.2.2.5 Reimbursement Scenario
  • 8.2.3 Canada
    • 8.2.3.1 Key Country Dynamics
    • 8.2.3.2 Canada flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.2.3.3 Competitive/Market Scenario
    • 8.2.3.4 Regulatory Framework
    • 8.2.3.5 Reimbursement Scenario
• 8.3 Europe
  • 8.3.1 Europe Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2 UK
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 UK Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2.3 Competitive/Market Scenario
    • 8.3.2.4 Regulatory Framework
    • 8.3.2.5 Reimbursement Scenario
  • 8.3.3 Germany
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Germany Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3.3 Competitive/Market Scenario
    • 8.3.3.4 Regulatory Framework
    • 8.3.3.5 Reimbursement Scenario
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 France Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4.3 Competitive Scenario
    • 8.3.4.4 Regulatory Framework
    • 8.3.4.5 Reimbursement Scenario
  • 8.3.5 Italy
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Italy Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5.3 Competitive/Market Scenario
    • 8.3.5.4 Regulatory Framework
    • 8.3.5.5 Reimbursement Scenario
  • 8.3.6 Spain
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Spain Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6.3 Competitive/Market Scenario
    • 8.3.6.4 Regulatory Framework
    • 8.3.6.5 Reimbursement Scenario
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Denmark Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7.3 Competitive/Market Scenario
    • 8.3.7.4 Regulatory Framework
    • 8.3.7.5 Reimbursement Scenario
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Sweden Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8.3 Competitive/Market Scenario
    • 8.3.8.4 Regulatory Framework
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Norway Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9.3 Competitive/Market Scenario
    • 8.3.9.4 Regulatory Framework
    • 8.3.9.5 Reimbursement Scenario
  • 8.3.10 Rest Of Europe Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 Japan Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2.3 Competitive/Market Scenario
    • 8.4.2.4 Regulatory Framework
    • 8.4.2.5 Reimbursement Scenario
  • 8.4.3 China
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 China Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3.3 Competitive/Market Scenario
    • 8.4.3.4 Regulatory Framework
    • 8.4.3.5 Reimbursement Scenario
  • 8.4.4 India
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 India Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4.3 Competitive/Market Scenario
    • 8.4.4.4 Regulatory Framework
    • 8.4.4.5 Reimbursement Scenario
  • 8.4.5 Australia
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 Australia Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5.3 Competitive/Market Scenario
    • 8.4.5.4 Regulatory Framework
    • 8.4.5.5 Reimbursement Scenario
  • 8.4.6 Thailand
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Thailand Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6.3 Competitive/Market Scenario
    • 8.4.6.4 Regulatory Framework
    • 8.4.6.5 Reimbursement Scenario
  • 8.4.7 South Korea
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 South Korea Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7.3 Competitive/Market Scenario
    • 8.4.7.4 Regulatory Framework
    • 8.4.7.5 Reimbursement Scenario
  • 8.4.8 Singapore
    • 8.4.8.1 Key Country Dynamics
    • 8.4.8.2 Singapore Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8.3 Competitive Scenario
    • 8.4.8.4 Regulatory Framework
    • 8.4.8.5 Reimbursement Scenario
  • 8.4.9 Rest Of Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Latin America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Brazil Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.5.2.3 Competitive/Market Scenario
    • 8.5.2.4 Regulatory Framework
    • 8.5.2.5 Reimbursement Scenario
  • 8.5.3 Mexico
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Mexico Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.5.3.3 Competitive/Market Scenario
    • 8.5.3.4 Regulatory Framework
    • 8.5.3.5 Reimbursement Scenario
  • 8.5.4 Argentina
    • 8.5.4.1 Key Country Dynamics
    • 8.5.4.2 Argentina Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.5.4.3 Competitive/Market Scenario
    • 8.5.4.4 Regulatory Framework
    • 8.5.4.5 Rest of Latin America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
• 8.6 MEA
  • 8.6.1 MEA Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
    • 8.6.2.3 Competitive Scenario
    • 8.6.2.4 Regulatory Framework
    • 8.6.2.5 Reimbursement Scenario
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Saudi Arabia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
    • 8.6.3.3 Competitive Scenario
    • 8.6.3.4 Regulatory Framework
    • 8.6.3.5 Reimbursement Scenario
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
    • 8.6.4.3 Competitive Scenario
    • 8.6.4.4 Regulatory Framework
    • 8.6.4.5 Reimbursement Scenario
  • 8.6.5 Kuwait
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
    • 8.6.5.3 Competitive Scenario
    • 8.6.5.4 Regulatory Framework
    • 8.6.5.5 Reimbursement Scenario
  • 8.6.6 Rest Of Mea Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 9 Competitive Landscape

• 9.1 Company Profiles
  • 9.7.1 DANAHER CORPORATION
    • 9.7.1.1 Company overview
    • 9.7.1.2 Beckman Coulter, Inc.
    • 9.7.1.2.1 Company Overview
    • 9.7.1.3 Cytiva
    • 9.7.1.3.1 Company Overview
    • 9.7.1.4 Financial performance
    • 9.7.1.5 Product benchmarking
    • 9.7.1.6 Strategic initiatives
  • 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
    • 9.7.2.1 Company overview
    • 9.7.2.2 Financial performance
    • 9.7.2.3 Product benchmarking
    • 9.7.2.4 Strategic initiatives
  • 9.7.3 SYSMEX CORPORATION
    • 9.7.3.1 Company overview
    • 9.7.3.2 Financial performance
    • 9.7.3.3 Product benchmarking
    • 9.7.3.4 Strategic initiatives
  • 9.7.4 AGILENT TECHNOLOGIES, INC.
    • 9.7.4.1 Company overview
    • 9.7.4.2 Financial performance
    • 9.7.4.3 Product benchmarking
    • 9.7.4.4 Strategic initiatives
  • 9.7.5 APOGEE FLOW SYSTEMS LTD.
    • 9.7.5.1 Company overview
    • 9.7.5.2 Product benchmarking
    • 9.7.5.3 Strategic initiatives
  • 9.7.6 BIO-RAD LABORATORIES, INC.
    • 9.7.6.1 Company overview
    • 9.7.6.2 Financial performance
    • 9.7.6.3 Product benchmarking
    • 9.7.6.4 Strategic initiatives
  • 9.7.7 THERMO FISHER SCIENTIFIC, INC.
    • 9.7.7.1 Company overview
    • 9.7.7.2 Financial performance
    • 9.7.7.3 Product benchmarking
    • 9.7.7.4 Strategic initiatives
  • 9.7.8 STRATEDIGM, INC.
    • 9.7.8.1 Company overview
    • 9.7.8.2 Product benchmarking
• 9.2 Company Categorization
• 9.3 Flow cytometry Market Share Analysis, 2023
• 9.4 Strategy Mapping
  • 9.4.1 Mergers & Acquisitions
  • 9.4.2 Partnerships And Collaborations
  • 9.4.3 New Product Launch
  • 9.4.4 Others

Chapter 10 Conclusion